This is a news story, published by Yahoo Finance, that relates primarily to Pfizer news.
For more personal finance & financial education news, you can click here:
more personal finance & financial education newsFor more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like personal finance & financial education news, you might also like this article about
Cheap Passive Income Stocks. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest passive income portfolio news, Passive income news, personal finance & financial education news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
broader passive income portfolioThe Motley Fool
•79% Informative
Toyota Motor trades at a forward price-to-earnings (P/E) ratio of 8 , which is significantly lower than the broader market.
Pfizer trades at just 10.9 times forward earnings at current levels, while Pfizer 's 5.94% dividend yield is among the highest in the entire healthcare sector.
Toyota and Pfizer both possess strong underlying businesses, well-established market positions, and financial resources to navigate industry challenges.
VR Score
76
Informative language
75
Neutral language
10
Article tone
semi-formal
Language
English
Language complexity
54
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
6
Source diversity
2
Affiliate links
no affiliate links